| CLASS | DRUG/TOX | LP7790-1 | 
| COMPONENT | Tobramycin^peak post extended interval dosing | LP308039-9 | 
| PROPERTY | MCnc | LP6827-2 | 
| TIME_ASPCT | Pt | LP6960-1 | 
| SYSTEM | Ser/Plas | LP7576-4 | 
| SCALE_TYP | Qn | LP7753-9 | 
| parent | Tobramycin | Serum or Plasma | Drug toxicology | LP389051-6 | 
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | mg/L;mcg/mL | |
| EXAMPLE_UCUM_UNITS | mg/L | |
| UNITSREQUIRED | N | |
| STATUS | ACTIVE | 
| LONG_COMMON_NAME | en-US | Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing | 
| LONG_COMMON_NAME | en-US | Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing | 
| SHORTNAME | en-US | Tobramycin Pk EID SerPl-mCnc | 
| ConsumerName | en-US | Tobramycin Peak after Extended Interval Dosing, Blood | 
| SHORTNAME | es-AR | tobramicina^pico después de intervalo de dosificación extendido:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo: | 
| SHORTNAME | pt-BR | Tobramycin Pk EID SerPl-mCnc | 
| LONG_COMMON_NAME | nl-NL | Tobramycine^piek na langdurige intervaldosering [massa/volume] in serum of plasma | 
| LONG_COMMON_NAME | es-MX | Tobramicina : Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: | 
LOINC Version: 2.78